Overview
- 6 inspections across 6 sites are on record.
- 10 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-05-24.
At a glance
Inspections
6
Sites
6
Observations
10
Career since
Feb 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Puma Biotechnology, Inc. | 24 May 2019 | Human Drugs | View 483 → |
| Francesco Muntoni, M.D. | 3 May 2019 | Human Drugs | View 483 → |
| Laurent Servais, M.D., PhD. | 26 Apr 2019 | Human Drugs | View 483 → |
| Intra-Cellular Therapies Inc | 22 Mar 2019 | Human Drugs | View 483 → |
| Tran-Johnson, Tram K. | 1 Feb 2019 | Human Drugs | View 483 → |
Sites inspected
Puma Biotechnology, Inc.Los Angeles, United States1 insp.
Francesco Muntoni, M.D.London, United Kingdom1 insp.
Laurent Servais, M.D., PhD.Paris, France1 insp.
Intra-Cellular Therapies IncNew York, United States1 insp.
Tran-Johnson, Tram K.San Diego, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Alanna L Mussawwir Bias2 shared
Diane C Van Leeuwen2 shared
Marilyn S Babu1 shared
Yangmin Ning1 shared
Bei Yu1 shared
Angela Shepas1 shared
Iram R Hassan1 shared
Phillip D Kronstein1 shared
Lakecha N Lewis1 shared
Full investigator report
Get the verbatim findings behind Ni A Khin's 10 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site